Welcome to the Annual Meeting for Nutex Health, Inc. Our host for today's call is Dr. Thomas T. Vo, Chief Executive Officer and Chairman. I will now turn the call over to your host. Dr. Vo, you may begin, sir.
Thank you. Good morning, everyone. This is the annual meeting of the stockholders of Nutex Health, Inc. My name is Thomas Vo, Chief Executive Officer and Chairman of the company, and I will be acting as the Chairman of this meeting. It is now 10:00 A.M. Central Time, and the meeting will please come to order. First, I would like to thank all the stockholders who are in attendance at this annual meeting. You are all participating virtually, and we truly appreciate your continued support of Nutex Health. We hope that by hosting our annual meeting virtually, we can increase access and participation. We will begin today's meeting with a formal agenda. I would now like to introduce the directors and members of the senior management of Nutex Health who are at the meeting today.
There's myself, Thomas Vo, Dr. Warren Hosseinion, the President, Mr. Jon Bates, our CFO, and Ms. Elisa Luqman, our COO. Also joining us today is Gisela Dannenberg of Troutman Pepper Locke, our outside corporate counsel, and Jennifer Parker of Grant Thornton LLP, our independent registered public accounting firm. We will now proceed with the formal business of the annual meeting. Elisa Luqman will act as secretary of the meeting. The agenda items for this meeting are 1, determining the presence of a quorum, 2, proposal one, election of directors, 3, proposal two, voting in an advisory capacity concerning the company's executive compensation, and 4, proposal three, ratification of the appointment of Grant Thornton LLP as our independent registered public accounting firm for the year ending December 31st, 2026. Stockholders may submit questions during this meeting in the space provided on the virtual annual meeting screen.
Questions from stockholders should pertain to the proposals being considered at this meeting or about the company's business. We will respond to stockholder questions by email as soon as practicable after the conclusion of this meeting. The first order of business is to determine the presence of a quorum. Pursuant to action of the board of directors, only holders of record of the shares of common stocks of the company at the close of business on February 27th, 2026, are entitled to vote at this meeting.
Mr. Chairman, I wish to report that I have examined the list of stockholders of common stock entitled to vote at this meeting and have determined that the number of shares of common stock outstanding at the record date February 27th, 2026, and entitled to vote is 5,628,591. I am advised by the Inspector of Elections that the number of shares of common stock represented at this meeting, participating virtually or by proxy, is not less than 2,814,297 shares, and a quorum is therefore constituted. Accordingly, the meeting is legally convened.
On the basis of the report of the secretary, a quorum is in attendance. Paul R. Ramirez of American Election Services, LLC has been appointed as Inspector of Election and has sworn to the oath of Inspector of Election. The next order of business is the approval of the election of seven directors to serve as members of the company's board of directors. The secretary will now present a resolution approving the election of seven directors to serve as members of the company's board of directors.
Resolved that the following persons be, and they hereby are, elected as the members of the board to hold office until the 2027 annual meeting, each of whom shall serve as members of the company's board. 1, Thomas T. Vo. 2, Warren Hosseinion. 3, Cheryl Grenas. 4, Michael L. Reed. 5, Scott J. Saunders. 6, Kelvin Spears. 7, Frank E. Jaumot. Further resolved that the officers of the company are hereby authorized and directed to take any and all actions necessary to effectuate the foregoing resolutions.
Will someone move for adoption of the resolutions?
Warren Hosseinion. I so move.
Jon Bates. I second the motion.
Thank you all. The next order of business is a non-binding advisory vote on the compensation of our named executive officers. The secretary will now present a resolution on an advisory vote on the compensation of our named executive officers.
Resolved that the compensation paid to Nutex Health Inc.'s named executive officers as disclosed pursuant to the compensation disclosure rules of the SEC, including the compensation tables and any related material disclosed in the proxy statement, be and hereby is approved. Further resolved that the officers of the company are hereby authorized and directed to take any and all actions necessary to effectuate the foregoing resolutions.
Will someone move for adoption of the resolution?
Warren Hosseinion. I don't move.
Jon Bates. I second the motion.
Thank you all. The next order of business is to ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the year ending December 31st, 2026. The secretary will now present the resolutions ratifying the appointment of Grant Thornton LLP as our independent registered public accounting firm for the year ending December 31st, 2026.
Resolved that the appointment of Grant Thornton LLP as our independent registered public accounting firm for the year ending December 31st, 2026, be and hereby is ratified and approved. Further resolved that the proper officers of the company are hereby directed to take any and all actions necessary to ratify appointment of Grant Thornton LLP as our independent registered public accounting firm for the year ending December 31st, 2026.
Will someone move for adoption of these resolutions?
Warren Hosseinion. I don't move.
Jon Bates. I second the motion.
Thank you all. It is now 10:08 A.M. Central Daylight Time, and the polls for voting on these proposals are now open. All stockholders entitled to vote at this meeting have the ability to do so online. All the stockholders of record who have not yet voted, please do so via the website used to access this meeting by using the control number assigned by Broadridge and Transfer Online, Inc. Please remember that if you have already voted by proxy, it is not necessary to vote again. We will now move to the next order of business.
Mr. Chairman, I am in possession and present the alphabetical list of stockholders of the company at the close of business on the record date who are entitled to vote at this meeting.
The list of stockholders is available for inspection on the virtual meeting website by any stockholder present and will remain open for inspection during this meeting. Each stockholder of record entitled to vote at this meeting was provided with notice of this meeting and has received a copy of the definitive proxy statement, including the notice of the meeting, which was distributed to stockholders commencing on or about March 13th, 2026, as evidenced by an affidavit of distribution by Broadridge, an authorized agent of Transfer Online, Inc., the transfer agent for the company's common stock. Unless there's a motion from the floor to the contrary, I suggest that a reading of the notice be waived. There was no motion. I declare the reading waived. The polls will close momentarily, so if you have not yet voted, please do so.
I now declare the polls closed at 10:11 A.M. Central Daylight Time on April 23rd, 2026. The votes will now be tabulated. Is the inspector of election ready to report the preliminary results of the voting on the proposal?
Mr. Chairman, I have tabulated the preliminary results of the votes cast on proposals at this annual meeting. The preliminary results of the voting are as follows. With respect to proposal one, the election of directors proposal, each director nominee has been approved by the affirmative vote of the holders of a plurality of the voting power of the shares present in person and by proxy and entitled to vote at this meeting. With respect to proposal two, the compensation paid to Nutex Health's named executive officers, as disclosed pursuant to the compensation disclosure rules of the SEC, has been approved by the affirmative vote of the holders of a majority of the voting power of the shares present in person and by proxy, and entitled to vote at this meeting.
With respect to proposal three, the ratification of the appointment of Grant Thornton LLP as the company's independent registered public accounting firm for the year ending December 31st, 2026, has been approved by the affirmative vote of the holders of a majority of the voting power of the shares present in person and by proxy and entitled to vote at this meeting.
Thank you, Mr. Ramirez. As indicated by the preliminary report of the inspector of election, all of the matters voted on by the stockholders have been approved. We will file the final report of the inspector of election with the records of this meeting. We expect to report the results of the voting on a Form 8-K to be filed with the SEC within four business days of this meeting. The Secretary will file the report of the inspector of elections as part of the records of this meeting. For the purposes of reference, the Secretary is directed to file the following additional papers with the records of the company. Number one, list of shareholders of common stock entitled to vote at this meeting. Number two, the proxy statement. Number three, affidavit of mailing. Number four, ballots and proxies presented to this meeting. Number five, inspector's oath.
Finally, number six, the report of the inspector of election. As there is no other business to come before the meeting, a motion to adjourn is in order.
Warren Hosseinion. I move the meeting be adjourned.
Jon Bates. I second the motion.
Moved and seconded that the meeting be adjourned. All in favor say aye.
Aye.
Aye.
Aye.
All opposed say nay. I declare the Nutex Health annual meeting of stockholders adjourned. Thank you everyone for attending today's meeting, and thank you everyone for your continued support of Nutex Health, Inc. Goodbye everyone.
The meeting has now concluded. Thank you for joining and have a pleasant day.
Thank you.